OTCMKTS:EMMBF

Emblem Competitors

$1.40
+0.02 (+1.45 %)
(As of 03/18/2019)
Add
Compare
Today's Range
$1.36
Now: $1.40
$1.45
50-Day Range
$1.40
MA: $1.40
$1.40
52-Week Range
$0.60
Now: $1.40
$1.63
Volume156,200 shs
Average Volume280,719 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Emblem (OTCMKTS:EMMBF) Vs. DDXS, TNGN, ATTBF, ADTX, AGNPF, and LBTSF

Should you be buying EMMBF stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Emblem, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), ADiTx Therapeutics (ADTX), Algernon Pharmaceuticals (AGNPF), and Almirall (LBTSF).

(DDXS) (OTCMKTS:DDXS) and Emblem (OTCMKTS:EMMBF) are both health technology companies, but which is the better stock? We will contrast the two companies based on the strength of their risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

Profitability

This table compares (DDXS) and Emblem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
EmblemN/AN/AN/A

Earnings and Valuation

This table compares (DDXS) and Emblem's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
EmblemN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (DDXS) and Emblem, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
Emblem0000N/A

(TNGN) (OTCMKTS:TNGN) and Emblem (OTCMKTS:EMMBF) are both health technology companies, but which is the better stock? We will contrast the two companies based on the strength of their risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

Earnings and Valuation

This table compares (TNGN) and Emblem's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(TNGN)N/AN/AN/AN/AN/A
EmblemN/AN/AN/AN/AN/A

Profitability

This table compares (TNGN) and Emblem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(TNGN)N/AN/AN/A
EmblemN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (TNGN) and Emblem, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(TNGN)0000N/A
Emblem0000N/A

Emblem (OTCMKTS:EMMBF) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, valuation and earnings.

Earnings & Valuation

This table compares Emblem and Abattis Bioceuticals' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EmblemN/AN/AN/AN/AN/A
Abattis BioceuticalsN/AN/AN/AN/AN/A

Profitability

This table compares Emblem and Abattis Bioceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EmblemN/AN/AN/A
Abattis BioceuticalsN/AN/AN/A

Analyst Recommendations

This is a summary of current recommendations for Emblem and Abattis Bioceuticals, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Emblem0000N/A
Abattis Bioceuticals0000N/A

Emblem (OTCMKTS:EMMBF) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, analyst recommendations, profitability, earnings and risk.

Analyst Ratings

This is a breakdown of current ratings for Emblem and ADiTx Therapeutics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Emblem0000N/A
ADiTx Therapeutics00103.00

Earnings and Valuation

This table compares Emblem and ADiTx Therapeutics' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EmblemN/AN/AN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/AN/AN/A

Profitability

This table compares Emblem and ADiTx Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EmblemN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/A

Summary

ADiTx Therapeutics beats Emblem on 1 of the 1 factors compared between the two stocks.

Algernon Pharmaceuticals (OTCMKTS:AGNPF) and Emblem (OTCMKTS:EMMBF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, profitability, analyst recommendations, risk and valuation.

Earnings & Valuation

This table compares Algernon Pharmaceuticals and Emblem's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Algernon PharmaceuticalsN/AN/AN/AN/AN/A
EmblemN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Algernon Pharmaceuticals and Emblem, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Algernon Pharmaceuticals0000N/A
Emblem0000N/A

Profitability

This table compares Algernon Pharmaceuticals and Emblem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Algernon PharmaceuticalsN/AN/AN/A
EmblemN/AN/AN/A

Emblem (OTCMKTS:EMMBF) and Almirall (OTCMKTS:LBTSF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership.

Earnings & Valuation

This table compares Emblem and Almirall's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EmblemN/AN/AN/AN/AN/A
AlmirallN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Emblem and Almirall, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Emblem0000N/A
Almirall01102.50

Profitability

This table compares Emblem and Almirall's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EmblemN/AN/AN/A
AlmirallN/AN/AN/A

Summary

Almirall beats Emblem on 1 of the 1 factors compared between the two stocks.


Emblem Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.00+0.0%$0.00N/A0.00
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02+0.6%$0.00N/A0.00
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.52+1.6%$0.00N/A0.00
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.12+5.8%$0.00N/A0.00Gap Down
Almirall logo
LBTSF
Almirall
0.5$15.15+1.0%$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08+0.0%$0.00N/A0.00Gap Up
ARNI
Arno Therapeutics
0.5$0.01+23.1%$0.00N/A0.00Gap Up
ASCLF
Ascletis Pharma
0.4$0.37+0.0%$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06+0.0%$0.00N/A0.00
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.56+8.7%$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52+0.0%$0.00N/A0.00News Coverage
BMEA
Biomea Fusion
0.0$16.79+1.3%$0.00N/A0.00High Trading Volume
Gap Up
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.18+10.8%$0.00N/A0.00News Coverage
ORHOF
CannaRoyalty
0.7$9.23+56.1%$0.00N/A0.00Gap Down
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.03+17.8%$0.00N/A0.00Gap Up
CGYG
China Longyi Group International
0.4$0.00+0.0%$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$23.20+0.0%$0.00N/A0.00
CELZ
Creative Medical Technology
0.5$0.03+12.3%$0.00N/A0.00Gap Up
Cybin logo
CLXPF
Cybin
0.7$1.35+3.7%$0.00N/A0.00News Coverage
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.01+20.0%$0.00N/A0.00Gap Down
ENZC
Enzolytics
0.0$0.14+3.3%$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
GB Sciences logo
GBLX
GB Sciences
0.5$0.05+1.6%$0.00N/A0.00News Coverage
Gap Up
Genfit logo
GNFTF
Genfit
0.5$4.52+0.0%$0.00N/A0.00
GMXAY
GENMAB A/S/S
0.5$35.59+1.0%$0.00N/A0.00High Trading Volume
Genus logo
GENSF
Genus
0.7$69.40+0.0%$0.00N/A0.00News Coverage
HALB
Halberd
0.0$0.04+12.3%$0.00N/A0.00News Coverage
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.57+3.6%$0.00N/A0.00Gap Down
Idorsia logo
IDRSF
Idorsia
0.5$28.40+2.3%$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5N/AN/A$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.24+7.4%$0.00N/A0.00
Kalytera Therapeutics logo
KALTF
Kalytera Therapeutics
0.6$0.04+18.4%$0.00N/A0.00Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00+0.0%$0.00N/A0.00Gap Up
Mesoblast logo
MEOBF
Mesoblast
0.5$1.73+0.0%$0.00N/A0.00
MCURF
Mind Cure Health
0.0$0.27+6.7%$0.00N/A0.00Gap Down
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$2.24+4.5%$0.00N/A0.00
Molecular Partners logo
MLLCF
Molecular Partners
0.5$25.19+3.6%$0.00N/A0.00
MPSYF
MorphoSys
0.0$92.50+2.2%$0.00N/A0.00
NRNVF
Nordic Nanovector ASA
0.0$1.64+0.0%$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$65.96+1.3%$0.00N/A0.00Gap Down
BPSR
Organicell Regenerative Medicine
0.5$0.05+2.2%$0.00N/A0.00Gap Up
Oxurion logo
TBGNF
Oxurion
0.5$2.94+0.0%$0.00N/A0.00
Pharnext logo
PNEXF
Pharnext
0.0$4.11+0.0%$0.00N/A0.00
PTEO
Proteo
0.5$0.09+0.0%$0.00N/A0.00
PROT
Proteonomix
0.5$0.01+0.0%$0.00N/A0.00Gap Down
ProtoKinetix logo
PKTX
ProtoKinetix
0.5$0.19+2.6%$0.00N/A0.00
PureTech Health logo
PTCHF
PureTech Health
0.0$5.71+1.1%$0.00N/A0.00
RCPHF
Recipharm AB (publ)
1.0$16.05+0.0%$0.00N/A0.00High Trading Volume
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.